According to PharSafer, a UK-based clinical research organization (CRO), employing the cloud-based software will allow it to exchange data with the market authorization holders. With the data being hosted in the cloud, it will allow the partners to utilize the system without the hurdle of differing IT systems.
Oracle Argus Cloud allows for the processing, analyzing, and reporting of adverse event cases, whether pre- or post-approval, internationally.
The last factor is of significance to PharSafer, as it has clients across seven continents and operates a 24-hour service.
In addition, Oracle notes that it is possible to integrate AI and machine learning tools to automate certain safety processes.
Alongside the deal to use Oracle’s platform, PharSafer will also join the ‘Oracle Health Sciences Safety Consortium’ – which has been organized to increase collaboration between those using Oracle’s services to participate in meetings, events, and working groups to ‘accelerate safety solutions’.
Oracle has signed a number of partnerships deal over the last year, as it broadens the scope of its data management platforms to streamline clinical trial planning, use of digital and database construction.
